Symbiotec Pharmalab Ltd Share Price History
NSE : 01 Sep, 2026
1097.7109.7 (11.1%)
Prev Close
988.0
Open Price
988.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
0
Today's High / Low
1180.0 / 934.2
52 WK High / Low
1180.0 / 934.2
Market Price of Symbiotec Pharmalab Ltd
1M
1Y
3Y
5Y
Monitoring Symbiotec Pharmalab Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 35.28 |
| YoY Gr. | - |
| Net Profit (Cr.) | 38 |
| BVPS | 280.16 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 10.19 |
| Op. Profit Mgn % | 15.05 |
| Net Profit Mgn % | 3.9 |
| Debt to Equity % | 0.65 |
Latest Shareholding
Promoters Holdings Over Time
About Symbiotec Pharmalab Ltd
- Symbiotec Pharmalab Private Limited was incorporated as a private limited company, dated September 20, 2002, with the Registrar of Companies, Madhya Pradesh and Chhattisgarh.
- Subsequently, the name of the Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26, 2025, was issued by the Central Processing Centre. Symbiotec is one of the few companies globally and only Indian manufacturer having continuous manufacturing for progesterone API manufacturing.
- The Company has its flow chemistry capability being utilized for progesterone in a new block in Pithampur facility.
- It is presently engaged in manufacturing and selling of Active Pharmaceuticals Ingredients (API) and Intermediates. The Company has a global leadership position in corticosteroid and steroidal-hormone active pharmaceutical ingredients.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Symbiotec Pharmalab Ltd's share price history?
Key events that impact Symbiotec Pharmalab Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Symbiotec Pharmalab Ltd's share price history?
Stock splits reduce the nominal price of Symbiotec Pharmalab Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Symbiotec Pharmalab Ltd?
Dividends can influence Symbiotec Pharmalab Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Symbiotec Pharmalab Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Symbiotec Pharmalab Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Symbiotec Pharmalab Ltd’s share price history?
To understand Symbiotec Pharmalab Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
